{
  "DOI": "10.1007/s10689-020-00192-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-020-00192-3",
  "alternative-id": [
    "192"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "26 February 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "2 June 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "6 June 2020"
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-0644-1790",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Scott",
      "given": "Anthony J.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Tokaz",
      "given": "Molly C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jacobs",
      "given": "Michelle F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chinnaiyan",
      "given": "Arul M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Phillips",
      "given": "Tycel J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wilcox",
      "given": "Ryan A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        6,
        6
      ]
    ],
    "date-time": "2020-06-06T02:02:17Z",
    "timestamp": 1591408937000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        6,
        5
      ]
    ],
    "date-time": "2021-06-05T23:31:32Z",
    "timestamp": 1622935892000
  },
  "funder": [
    {
      "DOI": "10.13039/100005189",
      "award": [
        "6503-16"
      ],
      "doi-asserted-by": "crossref",
      "name": "Leukemia and Lymphoma Society"
    },
    {
      "DOI": "10.13039/100000048",
      "award": [
        "129084-RSG-16–045-01-LIB"
      ],
      "doi-asserted-by": "crossref",
      "name": "American Cancer Society"
    },
    {
      "DOI": "10.13039/100000054",
      "award": [
        "K08CA172215"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Cancer Institute"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        6
      ]
    ],
    "date-time": "2023-09-06T00:48:00Z",
    "timestamp": 1693961280529
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2020,
        6,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            6,
            6
          ]
        ],
        "date-time": "2020-06-06T00:00:00Z",
        "timestamp": 1591401600000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            6,
            6
          ]
        ],
        "date-time": "2020-06-06T00:00:00Z",
        "timestamp": 1591401600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00192-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-020-00192-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00192-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "61-65",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        6,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        6,
        6
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/PO.16.00004",
      "author": "AM Goodman",
      "doi-asserted-by": "publisher",
      "journal-title": "JCO Precis Oncol",
      "key": "192_CR1",
      "unstructured": "Goodman AM, Choi M, Wieduwilt M et al (2017) Next generation sequencing reveals potentially actionable alterations in the majority of patients with lymphoid malignancies. JCO Precis Oncol. https://doi.org/10.1200/PO.16.00004",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jama.2017.11137",
      "author": "D Mandelker",
      "doi-asserted-by": "publisher",
      "first-page": "825",
      "issue": "9",
      "journal-title": "JAMA",
      "key": "192_CR2",
      "unstructured": "Mandelker D, Zhang L, Kemel Y et al (2017) Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing. JAMA 318(9):825–835. https://doi.org/10.1001/jama.2017.11137",
      "volume": "318",
      "year": "2017"
    },
    {
      "DOI": "10.1093/annonc/mdw018",
      "author": "F Meric-Bernstam",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "issue": "5",
      "journal-title": "Ann Oncol",
      "key": "192_CR3",
      "unstructured": "Meric-Bernstam F, Brusco L, Daniels M et al (2016) Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Ann Oncol 27(5):795–800. https://doi.org/10.1093/annonc/mdw018",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.18.00328",
      "author": "TP Slavin",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Oncol",
      "key": "192_CR4",
      "unstructured": "Slavin TP, Banks KC, Chudova D et al (2018) Identification of incidental germline mutations in patients with advanced solid tumors who underwent cell-free circulating tumor DNA sequencing. J Clin Oncol. https://doi.org/10.1200/JCO.18.00328",
      "year": "2018"
    },
    {
      "DOI": "10.1182/blood-2015-04-537498",
      "author": "JR Cerhan",
      "doi-asserted-by": "publisher",
      "first-page": "2265",
      "issue": "20",
      "journal-title": "Blood",
      "key": "192_CR5",
      "unstructured": "Cerhan JR, Slager SL (2015) Familial predisposition and genetic risk factors for lymphoma. Blood 126(20):2265–2273. https://doi.org/10.1182/blood-2015-04-537498",
      "volume": "126",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1365-2141.2009.07721.x",
      "author": "LR Goldin",
      "doi-asserted-by": "publisher",
      "first-page": "91",
      "issue": "1",
      "journal-title": "Br J Haematol",
      "key": "192_CR6",
      "unstructured": "Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O (2009) Highly increased familial risks for specific lymphoma subtypes. Br J Haematol 146(1):91–94. https://doi.org/10.1111/j.1365-2141.2009.07721.x",
      "volume": "146",
      "year": "2009"
    },
    {
      "DOI": "10.1038/bcj.2017.15",
      "author": "OC Leeksma",
      "doi-asserted-by": "publisher",
      "first-page": "e532",
      "issue": "2",
      "journal-title": "Blood Cancer J",
      "key": "192_CR7",
      "unstructured": "Leeksma OC, de Miranda NF, Veelken H (2017) Germline mutations predisposing to diffuse large B-cell lymphoma. Blood Cancer J 7(2):e532. https://doi.org/10.1038/bcj.2017.15",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1182/blood-2005-01-026690",
      "author": "DA Hill",
      "doi-asserted-by": "publisher",
      "first-page": "3161",
      "issue": "9",
      "journal-title": "Blood",
      "key": "192_CR8",
      "unstructured": "Hill DA, Wang SS, Cerhan JR et al (2006) Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 108(9):3161–3167. https://doi.org/10.1182/blood-2005-01-026690",
      "volume": "108",
      "year": "2006"
    },
    {
      "DOI": "10.1126/scitranslmed.3003161",
      "author": "S Roychowdhury",
      "doi-asserted-by": "publisher",
      "first-page": "111ra21",
      "issue": "111",
      "journal-title": "Sci Transl Med",
      "key": "192_CR9",
      "unstructured": "Roychowdhury S, Iyer MK, Robinson DR et al (2011) Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med 3(111):111ra21. https://doi.org/10.1126/scitranslmed.3003161",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1200/po.18.00011",
      "author": "DL Hertz",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "JCO Precis Oncol",
      "key": "192_CR10",
      "unstructured": "Hertz DL, Glatz A, Pasternak AL et al (2018) Integration of germline pharmacogenetics into a tumor sequencing program. JCO Precis Oncol 2:1–15. https://doi.org/10.1200/po.18.00011",
      "volume": "2",
      "year": "2018"
    },
    {
      "DOI": "10.3390/cancers11010011",
      "author": "N Galanina",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Cancers (Basel)",
      "key": "192_CR11",
      "unstructured": "Galanina N, Bejar R, Choi M et al (2018) Comprehensive genomic profiling reveals diverse but actionable molecular portfolios across hematologic malignancies: implications for next generation clinical trials. Cancers (Basel) 11(1):1–10. https://doi.org/10.3390/cancers11010011",
      "volume": "11",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ccr.2012.07.014",
      "author": "S Monti",
      "doi-asserted-by": "publisher",
      "first-page": "359",
      "issue": "3",
      "journal-title": "Cancer Cell",
      "key": "192_CR12",
      "unstructured": "Monti S, Chapuy B, Takeyama K et al (2012) Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 22(3):359–372. https://doi.org/10.1016/j.ccr.2012.07.014",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1182/blood-2008-01-129783",
      "author": "KH Young",
      "doi-asserted-by": "publisher",
      "first-page": "3088",
      "issue": "8",
      "journal-title": "Blood",
      "key": "192_CR13",
      "unstructured": "Young KH, Leroy K, Møller MB et al (2008) Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood 112(8):3088–3098. https://doi.org/10.1182/blood-2008-01-129783",
      "volume": "112",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gim.2017.196",
      "author": "JN Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "809",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "192_CR14",
      "unstructured": "Weitzel JN, Chao EC, Nehoray B et al (2018) Somatic TP53 variants frequently confound germ-line testing results. Genet Med 20(8):809–816. https://doi.org/10.1038/gim.2017.196",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pgen.1005945",
      "author": "PJ Byrd",
      "doi-asserted-by": "publisher",
      "first-page": "e1005945",
      "issue": "3",
      "journal-title": "PLoS Genet",
      "key": "192_CR15",
      "unstructured": "Byrd PJ, Stewart GS, Smith A et al (2016) A hypomorphic PALB2 allele gives rise to an unusual form of FA-N associated with lymphoid tumour development. PLoS Genet 12(3):e1005945. https://doi.org/10.1371/journal.pgen.1005945",
      "volume": "12",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "192_CR16",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497–506. https://doi.org/10.1056/NEJMoa1400382",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2015.65.0747",
      "author": "N Tung",
      "doi-asserted-by": "publisher",
      "first-page": "1460",
      "issue": "13",
      "journal-title": "J Clin Oncol",
      "key": "192_CR17",
      "unstructured": "Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34(13):1460–1468. https://doi.org/10.1200/JCO.2015.65.0747",
      "volume": "34",
      "year": "2016"
    },
    {
      "author": "A Liu",
      "first-page": "999",
      "issue": "4",
      "journal-title": "Oncol Rep",
      "key": "192_CR18",
      "unstructured": "Liu A, Takakuwa T, Fujita S et al (2008) ATR alterations in Hodgkin’s lymphoma. Oncol Rep 19(4):999–1005",
      "volume": "19",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2008.19.9802",
      "author": "I Zighelboim",
      "doi-asserted-by": "publisher",
      "first-page": "3091",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "192_CR19",
      "unstructured": "Zighelboim I, Schmidt AP, Gao F et al (2009) ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J Clin Oncol 27(19):3091–3096. https://doi.org/10.1200/JCO.2008.19.9802",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ajhg.2012.01.007",
      "author": "A Tanaka",
      "doi-asserted-by": "publisher",
      "first-page": "511",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "192_CR20",
      "unstructured": "Tanaka A, Weinel S, Nagy N et al (2012) Germline mutation in ATR in autosomal-dominant oropharyngeal cancer syndrome. Am J Hum Genet 90(3):511–517. https://doi.org/10.1016/j.ajhg.2012.01.007",
      "volume": "90",
      "year": "2012"
    },
    {
      "DOI": "10.1016/s1535-6108(03)00110-7",
      "author": "J Bartek",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "issue": "5",
      "journal-title": "Cancer Cell",
      "key": "192_CR21",
      "unstructured": "Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3(5):421–429. https://doi.org/10.1016/s1535-6108(03)00110-7",
      "volume": "3",
      "year": "2003"
    },
    {
      "DOI": "10.1371/journal.pone.0140819",
      "author": "O Havranek",
      "doi-asserted-by": "publisher",
      "first-page": "e0140819",
      "issue": "10",
      "journal-title": "PLoS ONE",
      "key": "192_CR22",
      "unstructured": "Havranek O, Kleiblova P, Hojny J et al (2015) Association of germline CHEK2 gene variants with risk and prognosis of non-hodgkin lymphoma. PLoS ONE 10(10):e0140819. https://doi.org/10.1371/journal.pone.0140819",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1101/531210",
      "doi-asserted-by": "crossref",
      "key": "192_CR23",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G et al (2019) Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv: 531210"
    },
    {
      "DOI": "10.1038/leu.2013.122",
      "author": "A Pardanani",
      "doi-asserted-by": "publisher",
      "first-page": "1870",
      "issue": "9",
      "journal-title": "Leukemia",
      "key": "192_CR24",
      "unstructured": "Pardanani A, Lasho TL, Laborde RR et al (2013) CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 27(9):1870–1873. https://doi.org/10.1038/leu.2013.122",
      "volume": "27",
      "year": "2013"
    },
    {
      "DOI": "10.1038/leu.2013.182",
      "author": "O Kosmider",
      "doi-asserted-by": "publisher",
      "first-page": "1946",
      "issue": "9",
      "journal-title": "Leukemia",
      "key": "192_CR25",
      "unstructured": "Kosmider O, Itzykson R, Chesnais V et al (2013) Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia. Leukemia 27(9):1946–1949. https://doi.org/10.1038/leu.2013.182",
      "volume": "27",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41467-019-09198-7",
      "author": "E Kaasinen",
      "doi-asserted-by": "publisher",
      "first-page": "1252",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "192_CR26",
      "unstructured": "Kaasinen E, Kuismin O, Rajamäki K et al (2019) Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans. Nat Commun 10(1):1252. https://doi.org/10.1038/s41467-019-09198-7",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1182/blood-2008-10-183392",
      "author": "VI Gaidzik",
      "doi-asserted-by": "publisher",
      "first-page": "4505",
      "issue": "19",
      "journal-title": "Blood",
      "key": "192_CR27",
      "unstructured": "Gaidzik VI, Schlenk RF, Moschny S et al (2009) Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. Blood 113(19):4505–4511. https://doi.org/10.1182/blood-2008-10-183392",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(1997)9:3\u003c209::AID-HUMU2\u003e3.0.CO;2-2",
      "author": "M Little",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "192_CR28",
      "unstructured": "Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9(3):209–225",
      "volume": "9",
      "year": "1997"
    }
  ],
  "reference-count": 28,
  "references-count": 28,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-020-00192-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "20"
}